ClinicalTrials.Veeva

Menu

Study to Determine the Digestive and Physiological Effects of an Extract From Bran in Healthy Men and Women

K

Kellogg´s

Status and phase

Completed
Phase 4

Conditions

Healthy

Treatments

Other: control wheat bran extract
Other: wheat bran extract

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01073969
PRV-08011

Details and patient eligibility

About

The primary objective of this trial is to determine whether two doses of an extract from bran demonstrate a prebiotic effect on colonic bacteria (by modulating selected fecal microbial populations, particularly bifidobacteria). The secondary objective is to measure the potential beneficial effects of consuming an extract from bran on the following physiological parameters: laxation, fecal pH, fecal moisture and stool consistency, blood glucose and insulin concentrations, plasma lipid profiles and serum free fatty acids, colonic bacterial short chain fatty acid production, ammonia metabolism and protein degradation, and biomarkers of oxidative stress and inflammation.

Enrollment

65 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female
  • 18-75 years of age
  • Body mass index ≥18.5 and <35.0 kg/m2
  • Fasting LDL-C level ≥100 mg/dL and <200 mg/dL
  • Otherwise judged to be in good health, willing to maintain habitual food and beverage intake and physical activity patterns throughout the trial

Exclusion criteria

  • Significant gastrointestinal condition
  • Use of pre/probiotic foods or supplements
  • Use of antibiotics
  • Pregnancy
  • Certain muscle, liver, kidney, lung or gastrointestinal conditions and medications
  • Poorly controlled hypertension
  • Cancer treated within prior 2 years

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

65 participants in 3 patient groups, including a placebo group

Control cereal
Placebo Comparator group
Description:
grain-based ready to eat cereal that does not contain active wheat bran extract
Treatment:
Other: control wheat bran extract
low dose
Active Comparator group
Description:
grain-based ready to eat cereal containing a low dose of wheat bran extract
Treatment:
Other: wheat bran extract
High dose
Active Comparator group
Description:
grain-based ready to eat cereal that contains a high dose of wheat bran extract
Treatment:
Other: wheat bran extract

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems